PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAbCellera Biologics
AbCellera Biologics(ABCL)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Etesevimab
healthy volunteers/patients
,
asymptomatic infections
,
sars-cov-2
,
severe acute respiratory syndrome-related coronavirus
,
covid-19
,
severe acute respiratory syndrome
,
disease progression
,
canavan disease
,
immunocompromised host
Bamlanivimab
covid-19
,
severe acute respiratory syndrome-related coronavirus
Bevifimod
healthy volunteers/patients
,
chronic renal insufficiency
,
drug delivery systems
,
hemostasis
,
prader-willi syndrome
,
hypercholesterolemia
,
leukemia
,
acute disease
,
blood coagulation disorders
,
hemostatic disorders
,
chronic kidney failure
,
rheumatoid arthritis
,
inflammation
,
depression
,
bipolar disorder
,
mood disorders
,
spinal muscular atrophy
,
spinal muscular atrophies of childhood
,
bone fractures
,
tibial fractures
,
noonan syndrome
,
growth disorders
,
hypoglycemia
,
hyperglycemia
,
asthma
,
chronic obstructive pulmonary disease
,
cystic fibrosis
,
wounds and injuries
,
diabetes mellitus
,
type 2 diabetes mellitus
,
type 1 diabetes mellitus
,
hemophilia a
,
laron syndrome
,
hemophilia b
,
pituitary dwarfism
,
inborn genetic diseases
,
obesity
,
turner syndrome
,
fatty liver
,
insulin resistance
,
atherosclerosis
,
arteriosclerosis
,
thrombasthenia
,
diabetic ketoacidosis
,
hemorrhage
,
postpartum hemorrhage
,
hypopituitarism
,
renal insufficiency
,
sepsis
,
respiratory insufficiency
,
surgical wound infection
,
diabetic neuropathies
,
gastrointestinal motility
,
dwarfism
,
achondroplasia
,
cardiovascular diseases
,
metabolic diseases
,
obstructive sleep apnea
,
non-alcoholic fatty liver disease
,
metabolic syndrome
,
overweight
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use